🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Connor J. Hagen

Melinta Therapeutics (United States)

ORCID: 0009-0000-2649-6284

Biochemistry, Genetics and Molecular BiologyMedicineMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases.”.

Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2024

N/A

0.330DataRank · unranked

8 citations

Allan J.W. Lui, Kota Ishizawa, Isao Miyazaki, Inna Khodos, Kentaro Wakayama +11 more

Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition

Blood(2020)10.1182/blood.2020008017

N/A

0DataRank · unranked

36 citations

Mandana T. Manzari, Laurie Herviou, Mariana Da Silva Ferreira, Connor J. Hagen, Hiroto Kiguchi +6 more

A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0310

N/A

0DataRank · unranked

4 citations

Payal T. Patel, Aleksandr Pankov, Jacob A. Boyer, Rajesh K. Soni, Isabella Del Priore +10 more